blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3949954

EP3949954 - PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  28.07.2023
Database last updated on 01.10.2024
FormerRequest for examination was made
Status updated on  05.08.2022
FormerThe application has been published
Status updated on  07.01.2022
Most recent event   Tooltip11.05.2024New entry: Decision on request for further processing 
Applicant(s)For all designated states
Astex Therapeutics Limited
436 Cambridge Science Park
Milton Road
Cambridge, Cambridgeshire, CB4 0QA / GB
[2022/06]
Inventor(s)01 / BROGGINI, Diego Fernando Domenico
CH-8200 Schaffhausen / CH
 [2022/06]
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2022/06]
Application number, filing date21184714.009.02.2016
[2022/06]
Priority number, dateEP2015015455410.02.2015         Original published format: EP 15154554
EP2015018898208.10.2015         Original published format: EP 15188982
[2022/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3949954
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)(Supplementary) European search report - dispatched on:EP10.01.2022
ClassificationIPC:A61K9/20, A61K9/48, A61K47/18, C07D403/04, A61K31/498, A61P35/00
[2022/06]
CPC:
A61K31/498 (EP,CN,IL,KR,US); A61K9/2018 (EP,IL,KR,US); A61K31/5513 (CN,IL);
A61K47/18 (EP,CN,IL,US); A61K47/26 (IL,KR,US); A61K9/2013 (CN,IL);
A61K9/2054 (EP,IL,KR,US); A61K9/4858 (EP,CN,IL,KR,US); A61P35/00 (EP,CN,IL);
A61P43/00 (EP,IL); C09K15/20 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/36]
Former [2022/06]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA09.07.2021
ME09.07.2021
Validation statesMA09.07.2021
MD09.07.2021
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE[2022/06]
English:PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE[2022/06]
French:COMPOSITIONS PHARMACEUTIQUES COMPRENANT N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE[2022/06]
Examination procedure02.08.2022Examination requested  [2022/36]
02.08.2022Date on which the examining division has become responsible
04.11.2022Amendment by applicant (claims and/or description)
31.07.2023Despatch of a communication from the examining division (Time limit: M06)
05.03.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
02.05.2024Reply to a communication from the examining division
Parent application(s)   TooltipEP16706551.5  / EP3256109
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
02.05.2024Request for further processing filed
02.05.2024Full payment received (date of receipt of payment)
Request granted
10.05.2024Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
04.11.2022Request for further processing filed
04.11.2022Full payment received (date of receipt of payment)
Request granted
14.11.2022Decision despatched
Fees paidRenewal fee
29.09.2021Renewal fee patent year 03
29.09.2021Renewal fee patent year 04
29.09.2021Renewal fee patent year 05
29.09.2021Renewal fee patent year 06
17.01.2022Renewal fee patent year 07
10.01.2023Renewal fee patent year 08
11.01.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inby applicantUS4666828
 US4683202
 US4801531
 US5192659
 US5272057
 US5882864
 US6218529
 WO2011135376
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.